Table 1.

Clinical Data

Case No. Sex/ Age Time of DiagnosisOrgan Involvement/ Stage-150Hb (g/dL) WBC (×109/L) WBC Differential Plt (×109/L) LDH-151 (U/L) TreatmentPresent Status
1  M/37  November 1993  Axillary lymph nodes/IB  14.5  6.5  Normal  233  265  RT (40 Gy) CR (May 1998)  
2  M/28  November 1997  Cervical, supraclavicular, mediastinal, abdominal and inguinal lymph nodes, spleen, liver/IIIB  11.3  7.7  Normal  356  269  CHOP LFU  
3  M/23  December 1997  Axillary, mediastinal lymph nodes/II  14.2  6.4  Normal  348  275  CHOP CR (May 1998) 
Case No. Sex/ Age Time of DiagnosisOrgan Involvement/ Stage-150Hb (g/dL) WBC (×109/L) WBC Differential Plt (×109/L) LDH-151 (U/L) TreatmentPresent Status
1  M/37  November 1993  Axillary lymph nodes/IB  14.5  6.5  Normal  233  265  RT (40 Gy) CR (May 1998)  
2  M/28  November 1997  Cervical, supraclavicular, mediastinal, abdominal and inguinal lymph nodes, spleen, liver/IIIB  11.3  7.7  Normal  356  269  CHOP LFU  
3  M/23  December 1997  Axillary, mediastinal lymph nodes/II  14.2  6.4  Normal  348  275  CHOP CR (May 1998) 

Abbreviations: RT, radiotherapy; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisone; CR, complete remission; LFU, lost to follow-up; WBC, white blood cell count; Plt, platelets; LDH, lactate dehydrogenase.

F0-150

Clinical stage according to the Ann Arbor classification.

F0-151

LDH normal range (240 to 480 U/L).

Close Modal

or Create an Account

Close Modal
Close Modal